Welcome to LookChem.com Sign In|Join Free

CAS

  • or

186293-26-5

Post Buying Request

186293-26-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

186293-26-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 186293-26-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,8,6,2,9 and 3 respectively; the second part has 2 digits, 2 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 186293-26:
(8*1)+(7*8)+(6*6)+(5*2)+(4*9)+(3*3)+(2*2)+(1*6)=165
165 % 10 = 5
So 186293-26-5 is a valid CAS Registry Number.

186293-26-5Relevant articles and documents

Silver(I) complexes with symmetrical Schiff bases: Synthesis, structural characterization, DFT studies and antimycobacterial assays

Paiva, Isabela L.,De Carvalho, Gustavo S.G.,Da Silva, Adilson D.,Corbi, Pedro P.,Bergamini, Fernando R.G.,Formiga, André L.B.,Diniz, Renata,Do Carmo, Weberton R.,Leite, Clarice Q.F.,Pavan, Fernando R.,Cuin, Alexandre

, p. 104 - 109 (2013)

Synthesis, structural and spectroscopic characterizations, molecular modeling and antimycobacterial assays of new silver(I) complexes with two Schiff bases - MBDA and MBDB - are reported. The complexes [Ag(MBDA) 2]NO3, or AgMBDA, and

Modeling and biological evaluation of 3,3′-(1,2-ethanediyl)bis[2-(4-methoxyphenyl)-thiazolidin-4-one], a new synthetic cyclooxygenase-2 inhibitor

Ottaná, Rosaria,Mazzon, Emanuela,Dugo, Laura,Monforte, Francesca,Maccari, Rosanna,Sautebin, Lidia,De Luca, Grazia,Vigorita, Maria Gabriella,Alcaro, Stefano,Ortuso, Francesco,Caputi, Achille P,Cuzzocrea, Salvatore

, p. 71 - 80 (2002)

Within the series of chiral 3,3′-(1,2-ethanediyl)bis[2-arylthiazolidin-4-ones], the 3,4-dimethoxyphenyl substituted derivative was found in the primary anti-inflammatory screening to be endowed with superior in vivo properties and good safety profile. Suc

Conformational and structural analysis of N-N′-bis (4-methoxybenzylidene)ethylenediamine

ünalero?lu,Temelli,H?kelek

, p. 91 - 95 (2001)

The Schiff base compound, N-N′-bis(4-methoxybenzylidene)ethylenediamine (C18H20N2O2) has been synthesized and its crystal structure has been investigated by X-ray analysis and PM3 method. The compound crystalliz

Design, synthesis and biological evaluation of Schiff’s base derivatives as multifunctional agents for the treatment of Alzheimer’s disease

Shi, Jian,Zhou, Yi,Wang, Keren,Ma, Qinge,Wei, Rongrui,Li, Qingfeng,Zhao, Yiyang,Qiao, Zhanpin,Liu, Shuang,Leng, Yumin,Liu, Wenmin,Sang, Zhipei

, p. 624 - 634 (2020/11/30)

A series of Schiff’s base derivatives was rationally designed, synthesized, and evaluated as multi-function agents for the treatment of Alzheimer’s disease (AD). The results revealed that compound 3b was a novel multifunctional agent. It acted as a highly selective monoamine oxidase-B inhibitor (IC50 = 8.4 nM), which was explained by the docking study. Compound 3b also was an antioxidant agent (2.3 eq) and could significantly inhibit self-induced Aβ1-42 aggregation (31.8%). Meanwhile, compound 3b was a selective metal chelator and could inhibit Cu2+-induced Aβ1-42 aggregation (62.3%). Furthermore, compound 3b presented good neuroprotective effects on H2O2-induced PC12 cell injury. More importantly, compound demonstrated good blood brain barrier permeability and druglike properties. Therefore, compound 3b, a promising multi-targeted active molecule, offers an attractive starting point for further study in the drug-discovery process against AD.[Figure not available: see fulltext.].

Synthesis and biological evaluation of novel cYY analogues targeting Mycobacterium tuberculosis CYP121A1

Kishk, Safaa M.,McLean, Kirsty J.,Sood, Sakshi,Helal, Mohamed A.,Gomaa, Mohamed S.,Salama, Ismail,Mostafa, Samia M.,de Carvalho, Luiz Pedro S.,Munro, Andrew W.,Simons, Claire

supporting information, p. 1546 - 1561 (2019/03/05)

The rise in multidrug resistant (MDR) cases of tuberculosis (TB) has led to the need for the development of TB drugs with different mechanisms of action. The genome sequence of Mycobacterium tuberculosis (Mtb) revealed twenty different genes coding for cy

Molybdenum-catalyzed diastereoselective anti-dihydroxylation of secondary allylic alcohols

Su, Shixia,Wang, Chuan

supporting information, p. 2436 - 2440 (2019/03/29)

In this protocol, we report a Mo-catalyzed anti-dihydroxylation of secondary allylic alcohols, providing a general method for the preparation of 1,2,3-triols bearing up to three continuous stereocenters with excellent diastereocontrol. The mechanistic studies reveal that this dihydroxylation reaction consists of two steps and up to excellent diastereomeric ratios of the final triol products can be achieved due to the high level of both diastereocontrol in the initial epoxidation and regiocontrol in the following hydrolysis in situ.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 186293-26-5